Healthcare provider profile · identity verified

Rasbinder Singh

Physician Assistant · BAKERSFIELD, CA · NPI 1609183680

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Rosuvastatin Calcium	Rosuvastatin Calcium	914	208
Amlodipine Besylate	Amlodipine Besylate	829	174
Losartan Potassium	Losartan Potassium	639	133
Atorvastatin Calcium	Atorvastatin Calcium	578	126
Telmisartan	Telmisartan	538	130
Levothyroxine Sodium	Levothyroxine Sodium	497	90
Omeprazole	Omeprazole	466	90
Celecoxib	Celecoxib	463	126
Gabapentin	Gabapentin	453	110
Pioglitazone Hcl	Pioglitazone Hcl	390	81
Metformin Hcl	Metformin Hcl	387	86
Lansoprazole	Lansoprazole	359	94
Tamsulosin Hcl	Tamsulosin Hcl	345	83
Azithromycin	Azithromycin	322	203
Pantoprazole Sodium	Pantoprazole Sodium	315	65
Metoprolol Tartrate	Metoprolol Tartrate	240	49
Clopidogrel	Clopidogrel Bisulfate	231	50
Montelukast Sodium	Montelukast Sodium	222	53
Jardiance	Empagliflozin	213	51
Glipizide	Glipizide	203	51
Alendronate Sodium	Alendronate Sodium	199	32
Furosemide	Furosemide	195	51
Lisinopril	Lisinopril	185	40
Allopurinol	Allopurinol	182	42
Metoprolol Succinate	Metoprolol Succinate	182	39
Tradjenta	Linagliptin	178	43
Linzess	Linaclotide	177	52
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	167	28
Baclofen	Baclofen	157	49
Ibuprofen	Ibuprofen	138	68
Clonidine Hcl	Clonidine Hcl	136	41
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	132	86
Hydralazine Hcl	Hydralazine Hcl	129	35
Trazodone Hcl	Trazodone Hcl	128	24
Januvia	Sitagliptin Phosphate	123	30
Glimepiride	Glimepiride	103	21
Ofloxacin	Ofloxacin	103	64
Cephalexin	Cephalexin	96	75
Metformin Hcl Er	Metformin Hcl	95	19
Azelastine Hcl	Azelastine Hcl	92	51
Sertraline Hcl	Sertraline Hcl	91	21
Eliquis	Apixaban	90	17
Farxiga	Dapagliflozin Propanediol	89	20
Hydrochlorothiazide	Hydrochlorothiazide	89	21
Atenolol	Atenolol	87	24
Pregabalin	Pregabalin	84	17
Carvedilol	Carvedilol	82	23
Famotidine	Famotidine	81	28
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	81	47
Alprazolam	Alprazolam	80	28
Esomeprazole Magnesium	Esomeprazole Magnesium	80	16
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	78	62
Ciprofloxacin Hcl	Ciprofloxacin Hcl	77	63
Buspirone Hcl	Buspirone Hcl	72	16
Doxycycline Hyclate	Doxycycline Hyclate	71	54
Albuterol Sulfate Hfa	Albuterol Sulfate	70	40
Myrbetriq	Mirabegron	69	18
Janumet	Sitagliptin Phos/Metformin Hcl	68	21
Meloxicam	Meloxicam	67	27
Ondansetron Hcl	Ondansetron Hcl	64	33
Methotrexate	Methotrexate Sodium	60	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	60	15
Quetiapine Fumarate	Quetiapine Fumarate	59	17
Breo Ellipta	Fluticasone/Vilanterol	58	20
Donepezil Hcl	Donepezil Hcl	57	19
Potassium Chloride	Potassium Chloride	57	23
Meclizine Hcl	Meclizine Hcl	56	37
Triamcinolone Acetonide	Triamcinolone Acetonide	56	44
Isosorbide Mononitrate Er	Isosorbide Mononitrate	55	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	54	32
Finasteride	Finasteride	51	15
Ozempic	Semaglutide	51	suppressed
Fluticasone Propionate	Fluticasone Propionate	50	34
Fenofibrate	Fenofibrate Nanocrystallized	48	12
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	47	suppressed
Amoxicillin	Amoxicillin	46	40
Acetaminophen-Codeine	Acetaminophen With Codeine	41	19
Escitalopram Oxalate	Escitalopram Oxalate	40	12
Nebivolol Hcl	Nebivolol Hcl	40	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	39	14
Oxybutynin Chloride Er	Oxybutynin Chloride	39	13
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	38	12
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	38	14
Tramadol Hcl	Tramadol Hcl	38	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	37	suppressed
Oxycodone Hcl	Oxycodone Hcl	37	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	35	suppressed
Mupirocin	Mupirocin	34	28
Simvastatin	Simvastatin	34	suppressed
Lorazepam	Lorazepam	33	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	33	suppressed
Duloxetine Hcl	Duloxetine Hcl	32	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	32	18
Janumet Xr	Sitagliptin Phos/Metformin Hcl	31	suppressed
Procto-Med Hc	Hydrocortisone	30	18
Digoxin	Digoxin	29	suppressed
Levofloxacin	Levofloxacin	29	26
Nystatin	Nystatin	29	20
Prasugrel Hcl	Prasugrel Hcl	29	suppressed
Incruse Ellipta	Umeclidinium Bromide	28	suppressed
Ventolin Hfa	Albuterol Sulfate	28	suppressed
Lactulose	Lactulose	26	17
Loperamide	Loperamide Hcl	26	18
Pentips Pen Needle	Pen Needle, Diabetic	24	11
Fluconazole	Fluconazole	23	19
Naproxen	Naproxen	23	16
Prednisone	Prednisone	23	18
Spironolactone	Spironolactone	23	suppressed
Dutasteride	Dutasteride	22	suppressed
Xarelto	Rivaroxaban	22	suppressed
Dapagliflozin	Dapagliflozin Propanediol	21	11
Ezetimibe	Ezetimibe	21	suppressed
Methimazole	Methimazole	21	suppressed
Ropinirole Hcl	Ropinirole Hcl	21	suppressed
Amiodarone Hcl	Amiodarone Hcl	20	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	20	15
Propranolol Hcl	Propranolol Hcl	20	suppressed
Citalopram Hbr	Citalopram Hydrobromide	19	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	19	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	19	suppressed
Terbinafine Hcl	Terbinafine Hcl	19	suppressed
Topiramate	Topiramate	19	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	19	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	18	suppressed
Aripiprazole	Aripiprazole	18	suppressed
Levetiracetam	Levetiracetam	18	suppressed
Clonazepam	Clonazepam	17	suppressed
Fluocinolone Acetonide Oil	Fluocinolone Acetonide Oil	17	12
Ketoconazole	Ketoconazole	17	11
Nitroglycerin	Nitroglycerin	17	12
Diclofenac Sodium	Diclofenac Sodium	16	11
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	16	suppressed
Latanoprost	Latanoprost	16	suppressed
Lidocaine	Lidocaine	16	suppressed
Methocarbamol	Methocarbamol	16	suppressed
Glyburide	Glyburide	15	suppressed
Memantine Hcl	Memantine Hcl	15	suppressed
Metronidazole	Metronidazole	15	13
Neomycin-Polymyxin-Dexameth	Neomycin/Polymyxin B/Dexametha	15	suppressed
Olanzapine	Olanzapine	15	suppressed
Clindamycin Hcl	Clindamycin Hcl	14	suppressed
Glipizide Er	Glipizide	14	suppressed
Bupropion Hcl	Bupropion Hcl	13	suppressed
Memantine Hcl Er	Memantine Hcl	13	suppressed
Erythromycin	Erythromycin Base	12	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	12	suppressed
Mounjaro	Tirzepatide	12	suppressed
Symbicort	Budesonide/Formoterol Fumarate	12	suppressed
Ultra-Fine Micro Pen Needle	Pen Needle, Diabetic	12	suppressed
Brilinta	Ticagrelor	11	suppressed
Vascepa	Icosapent Ethyl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error